Recent Advances on the Pathogenesis of Huntington's Disease

Albin, 1995, Genetics and molecular biology of Huntington's disease, Trends Neurosci., 18, 11, 10.1016/0166-2236(95)93943-R Alexi, 1998, 3-Nitroproprionic acid's lethal triplet: Cooperative pathways of neurodegeneration, Neuroreport, 9, R57, 10.1097/00001756-199808030-00001 Ambrose, 1994, Structure and expression of the Huntington's disease gene: Evidence against simple inactivation due to an expanded CAG repeat, Somat. Cell Mol. Genet., 20, 27, 10.1007/BF02257483 Andrade, 1995, HEAT repeats in the Huntington's disease protein, Nature Genet., 11, 115, 10.1038/ng1095-115 Andrew, 1993, The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease, Nature Genet., 4, 398, 10.1038/ng0893-398 Ankarcrona, 1995, Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function, Neuron, 15, 961, 10.1016/0896-6273(95)90186-8 Ankarcrona, 1996, Calcineurin and mitochondrial function in glutamate induced neuronal apoptosis, FEBS Lett., 394, 321, 10.1016/0014-5793(96)00959-3 Aronin, 1995, CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain, Neuron, 15, 1193, 10.1016/0896-6273(95)90106-X Arzberger, 1997, Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease-An in situ hybridization study, J. Neuropathol. Exp. Neurol., 56, 440, 10.1097/00005072-199704000-00013 Ashizawa, 1994, CAG repeat size and clinical presentation in Huntington's disease, Neurology, 44, 1137, 10.1212/WNL.44.6.1137 Augood, 1997, Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease, Ann. Neurol., 42, 215, 10.1002/ana.410420213 Bao, 1996, Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin, Proc. Natl. Acad. Sci. USA, 93, 5037, 10.1073/pnas.93.10.5037 Beal, 1986, Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid, Nature, 321, 168, 10.1038/321168a0 Beal, 1989, Chronic quinolinic acid lesions in rats closely resemble Huntington's disease, J. Neurosci., 11, 1649, 10.1523/JNEUROSCI.11-06-01649.1991 Beal, 1992, Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses, Ann. Neurol., 31, 119, 10.1002/ana.410310202 Beal, 1993, Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate, J. Neurochem., 61, 1147, 10.1111/j.1471-4159.1993.tb03633.x Beal, 1993, Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases, Trends Neurosci., 16, 125, 10.1016/0166-2236(93)90117-5 Beal, 1995, Aging, energy and oxidative stress in neurodegenerative diseases, Ann. Neurol., 38, 357, 10.1002/ana.410380304 Becher, 1998, Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions andIT15, Neurobiol. Dis., 4, 387, 10.1006/nbdi.1998.0168 Behrens, 1995, 3-nitroproprionic acid induces apoptosis in cultured striatal and cortical neurons, Neuroreport, 6, 545, 10.1097/00001756-199502000-00034 Block-Galarza, 1997, Fast transport and retrograde movement of huntingtin and HAP1 in axons, Neuroreport, 8, 2247, 10.1097/00001756-199707070-00031 Bots, 1987, Neuropathological changes of the nucleus accumbens in Huntington's chorea, Acta Neuropathol., 55, 21, 10.1007/BF00691525 Brandt, 1996, Trinucleotide repeat length and clinical progression in Huntington's disease, Neurology, 46, 527, 10.1212/WNL.46.2.527 Bredesen, 1995, Neural apoptosis, Ann. Neurol., 38, 839, 10.1002/ana.410380604 Bredt, 1991, Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase, Neuron, 7, 615, 10.1016/0896-6273(91)90374-9 Burke, 1996, Huntingtin and DRPLA proteins selectively interact with the enzyme GADPH, Nature Med., 2, 347, 10.1038/nm0396-347 Butterworth, 1998, Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum, Neuroscience, 87, 49, 10.1016/S0306-4522(98)00129-8 Cammarata, 1993, Ubiquitin-reactive neurites in cerebral cortex of subjects with Huntington's chorea: A pathological correlate of dementia, Neurosci. Lett., 156, 96, 10.1016/0304-3940(93)90448-T Cariello, 1996, Transglutaminase activity is related to CAG repeat length in patients with Huntington's disease, Hum. Genet., 98, 633, 10.1007/s004390050273 Cha, 1998, Altered brain neurotransmittor receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene, Proc. Natl. Acad. Sci. USA, 95, 6480, 10.1073/pnas.95.11.6480 Chase, 1998, Neuroanatomical features of a transgenic model of Huntington's disease, Soc. Neurosci. Abstr., 380.5 Claes, 1995, Correlations between triplet repeat expansion and clinical features in Huntington's disease, Arch. Neurol., 52, 749, 10.1001/archneur.1995.00540320021009 Colomer, 1997, Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain, Hum. Mol. Genet., 6, 1519, 10.1093/hmg/6.9.1519 Coyle, 1976, Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea, Nature, 263, 244, 10.1038/263244a0 Coyle, 1993, Oxidative stress, glutamate, and neurodegenerative disorders, Science, 262, 689, 10.1126/science.7901908 Davies, 1997, Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell, 90, 537, 10.1016/S0092-8674(00)80513-9 Davies, 1998, Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions, Lancet, 351, 131, 10.1016/S0140-6736(97)08360-8 Dawson, 1991, Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissue, Proc. Natl. Acad. Sci. USA, 88, 7797, 10.1073/pnas.88.17.7797 Dawson, 1993, Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures, J. Neurosci., 13, 2651, 10.1523/JNEUROSCI.13-06-02651.1993 Dawson, 1996, Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice, J. Neurosci., 16, 2479, 10.1523/JNEUROSCI.16-08-02479.1996 De Rooij, 1996, Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation, Hum. Mol. Genet., 5, 1093, 10.1093/hmg/5.8.1093 Dickson, 1995, Apoptosis in the brain, Am. J. Pathol., 146, 1040 DiFiglia, 1995, Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons, Neuron, 14, 1075, 10.1016/0896-6273(95)90346-1 DiFiglia, 1997, Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science, 277, 1990, 10.1126/science.277.5334.1990 DiMauro, 1998, Mitochondrial DNA and diseases of the nervous system: The spectrum, Neuroscientist, 4, 53, 10.1177/107385849800400113 Doble, 1995, Excitatory amino acid receptors and neurodegeneration, Therapie, 50, 319 Dugan, 1995, Mitochondrial production of reactive oxygen species in cortical nertons following exposure toNd, J. Neurosci., 15, 6377, 10.1523/JNEUROSCI.15-10-06377.1995 Duyao, 1995, Inactivation of the mouse Huntington's disease gene homologHdh, Science, 269, 407, 10.1126/science.7618107 Dragunow, 1995, In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes, Neuroreport, 6, 1053, 10.1097/00001756-199505090-00026 Engelender, 1997, Huntingtin-associated protein 1 (HAP1) interacts with the p150 Glued subunit of dynactin, Hum. Mol. Genet., 6, 2205, 10.1093/hmg/6.13.2205 Farrer, 1984, The natural history of Huntington's disease: Possible role of “aging genes.”, Am. J. Hum. Genet., 18, 115, 10.1002/ajmg.1320180115 Farrer, 1992, Inverse relationship between age at onset of Huntington's disease and paternal age suggests involvement of genetic imprinting, Am. J. Hum. Genet., 50, 528 Ferrante, 1987, Morphologic and histochemical characteristics of a spared subset of neurons in Huntington's disease, J. Neuropathol. Exp. Neurol., 46, 12, 10.1097/00005072-198701000-00002 Ferrante, 1997, Heterogenous topographic and cellular distribution of huntingtin expression in the normal human neostriatum, J. Neurosci., 17, 3052, 10.1523/JNEUROSCI.17-09-03052.1997 Fesus, 1988, Searching for function of tissue transglutaminase: Its possible involvement in biochemical pathway of programmed cell death, Adv. Expl. Biol., 231, 119 Fujita, 1995, Alteration of transglutaminase activity in rat and human spinal cord after neuronal degeneration, Neurochem. Res., 20, 1195, 10.1007/BF00995383 Gavrieli, 1992, Identification of programmed cell deathin situ, J. Cell Biol., 119, 493, 10.1083/jcb.119.3.493 Gegelashvili, 1997, High affinity glutamate transporters: Regulation of expression and activity, Mol. Pharmacol., 52, 6, 10.1124/mol.52.1.6 Gerber, 1994, Transcriptional activation modulated by homopolymeric glutamine and proline stretches, Science, 263, 808, 10.1126/science.8303297 Gerfen, 1992, The neostriatal mosaic: Multiple levels of compartmental organization, Trends Neurosci., 15, 133, 10.1016/0166-2236(92)90355-C Goldberg, 1996, Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract, Nature Genet., 13, 442, 10.1038/ng0896-442 Gonzalez-Zulueta, 1998, Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity, J. Neurosci., 18, 2040, 10.1523/JNEUROSCI.18-06-02040.1998 Gourfinkel-An, 1997, Differential distribution of the normal and mutated forms of huntingtin in the human brain, Ann. Neurol., 42, 712, 10.1002/ana.410420507 Grafton, 1992, Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease, Arch. Neurol., 49, 1161, 10.1001/archneur.1992.00530350075022 Greene, 1995, Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate, J. Neurochem., 64, 430, 10.1046/j.1471-4159.1995.64010430.x Gu, 1996, Mitochondrial defect in Huntington's disease caudate nucleus, Ann. Neurol., 39, 385, 10.1002/ana.410390317 Gusella, 1983, A polymorphic DNA marker genetically linked to Huntington's disease, Nature, 306, 234, 10.1038/306234a0 Gusella, 1993, Molecular genetics of Huntington's disease, Arch. Neurol., 50, 1157, 10.1001/archneur.1993.00540110037003 Gutekunst, 1995, Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein anti-bodies, Proc. Natl. Acad. Sci. USA, 92, 8710, 10.1073/pnas.92.19.8710 Hackam, 1998, The fatal attraction of polyglutamine-containing proteins, Clin. Genet., 53, 233, 10.1111/j.1399-0004.1998.tb02687.x Hand, 1993, Cellular transglutaminases in neural development, Int. J. Dev. Neurosci., 11, 709, 10.1016/0736-5748(93)90060-Q Harper, 1992, The epidemiology of Huntington's disease, Hum. Genet., 89, 365, 10.1007/BF00194305 Hedreen, 1991, Neuronal loss in layer V and VI of cerebral cortex in Huntington's disease, Neurosci. Lett., 133, 257, 10.1016/0304-3940(91)90583-F Hedreen, 1995, Early loss of neostriatal striosome neurones in Huntington's disease, J. Neuropathol. Exp. Neurol., 54, 105, 10.1097/00005072-199501000-00013 Hodgson, 1998, YAC transgenic mice expressing mutant human huntington show deficits in hippocampal long-term potentiation, Soc. Neurosci. Abstr., 127.1 Hoogeveen, 1993, Characterization and localization of the Huntington's disease gene product, Hum. Mol. Genet., 2, 2069, 10.1093/hmg/2.12.2069 Hope, 1991, Neuronal NADPH diaphorase is a nitric oxide synthase, Proc. Natl. Acad. Sci. USA, 88, 2811, 10.1073/pnas.88.7.2811 Huang, 1995, Quinolinic acid-induced increases in calbindin D28K immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease, Neuroscience, 65, 397, 10.1016/0306-4522(94)00494-P 1993, Cell, 72, 971, 10.1016/0092-8674(93)90585-E Jenkins, 1993, Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy, Neurology, 43, 2689, 10.1212/WNL.43.12.2689 Jones, 1997, Huntington's disease: Advances in molecular and cell biology, J. Inherit. Metab. Dis., 20, 125, 10.1023/A:1005340302695 Kahlem, 1998, Transglutaminase action imitates Huntington's disease: Selective polymerization of Huntingtin containing expanded polyglutamine, Mol. Cell, 1, 595, 10.1016/S1097-2765(00)80059-3 Kalchman, 1996, Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme, J. Biol. Chem., 271, 19385, 10.1074/jbc.271.32.19385 Kalchman, 1997, HIP1,S. cerevisiae Sla2p,, Nature Genet., 16, 44, 10.1038/ng0597-44 Kerr, 1972, Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics, Br. J. Cancer, 26, 239, 10.1038/bjc.1972.33 Koh, 1986, Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity, Science, 234, 73, 10.1126/science.2875522 Koshy, 1996, Spinocerbellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase, Hum. Mol. Genet., 5, 1311, 10.1093/hmg/5.9.1311 Kowall, 1987, Patterns of cell loss in Huntington's disease, Trends Neurosci., 10, 24, 10.1016/0166-2236(87)90120-2 Krawczak, 1991, Covariate-dependent age-at-onset distributions for Huntington's disease, Am. J. Hum. Genet., 49, 735 Kremer, 1993, AMPA and NMDA binding sites in the hypothalamic lateral tuberal nucleus: Implications for Huntington's disease, Neurology, 43, 1593, 10.1212/WNL.43.8.1593 Kremer, 1990, Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's Disease, J. Neuropathol. Exp. Neurol., 49, 371, 10.1097/00005072-199007000-00002 Kremer, 1992, Weight loss in Huntington's disease, Arch. Neurol., 49, 349, 10.1001/archneur.1992.00530280029014 Kuwert, 1990, Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease, Brain, 113, 1405, 10.1093/brain/113.5.1405 Laforet, 1998, Development and characterization of a novel transgenic model of Huntington's disease which recapitulates features of the human illness, Soc. Neurosci. Abstr., 380.8 Leist, 1998, Apoptosis, excitotoxicity, and neuropathology, Exp. Cell Res., 239, 183, 10.1006/excr.1997.4026 Levine, 1998, Enhanced sensitivity to glutamate receptor activation in mouse models of Huntington's disease, Soc. Neurosci. Abstr., 380.7 Li, 1998, Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats, Hum. Mol. Genet., 7, 777, 10.1093/hmg/7.5.777 Li, 1995, A huntingtin-associated protein enriched in brain with implications for pathology, Nature, 378, 398, 10.1038/378398a0 Li, 1996, Huntingtin-associated protein (HAP1): Discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase, Proc. Natl. Acad. Sci. USA, 93, 4839, 10.1073/pnas.93.10.4839 Lipton, 1993, A redox-based mechanism for neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds, Nature, 364, 626, 10.1038/364626a0 Lipton, 1994, Excitatory amino acids as a final common pathway for neurological disorders, N. Engl. J. Med., 330, 613, 10.1056/NEJM199403033300907 Ludolph, 1991, 3-Nitropropionic acid-exogenous animal toxin and possible human striatal toxin, Can. J. Neurol. Sci., 18, 492, 10.1017/S0317167100032212 MacDonald, 1996, Huntington's disease: Translating a CAG repeat into a pathogenetic model, Curr. Opin. Neurobiol., 6, 638, 10.1016/S0959-4388(96)80097-3 MacMillan, 1996, The neurobiology of Huntington's disease Mangiarini, 1996, Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice, Cell, 87, 493, 10.1016/S0092-8674(00)81369-0 Mangiarini, 1997, Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation, Nature Genet., 15, 197, 10.1038/ng0297-197 Manzoni, 1992, Nitric oxide-induced blockade of NMDA receptors, Neuron, 8, 653, 10.1016/0896-6273(92)90087-T Matthews, 1997, Iodoacetate produces striatal excitotoxic lesions, J. Neurochem., 69, 285, 10.1046/j.1471-4159.1997.69010285.x McGeer, 1978, Kainate-induced degeneration of neostriatal neurons: Dependency upon corticostriatal tract, Brain Res., 139, 381, 10.1016/0006-8993(78)90941-1 McLaughlin, 1998, Methylmalonate toxicity in primary neuronal cultures, Neuroscience, 86, 279, 10.1016/S0306-4522(97)00594-0 McNeil, 1997, Reduced penetrance of the Huntington's disease mutation, Hum. Mol. Genet., 6, 775, 10.1093/hmg/6.5.775 Metzler, 1998, Conditional inactivation of huntingtin in transgenic mice, Soc. Neurosci. Abstr., 380.4 Monaghan, 1989, The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system, Annu. Rev. Pharmacol. Toxicol., 29, 365, 10.1146/annurev.pa.29.040189.002053 Monckton, 1995, Unstable triplet repeat diseases, Circulation, 91, 513, 10.1161/01.CIR.91.2.513 Morris, 1996, Psychiatric aspects of Huntington's disease, 73 Nakao, 1996 Nakao, 1997, Effects of alpha-phenyl-tert, Neuroscience, 76, 749, 10.1016/S0306-4522(96)00223-0 Nasir, 1995, Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes, Cell, 81, 811, 10.1016/0092-8674(95)90542-1 Nicholson, 1997, Caspases: Killer proteins, Trends Biochem. Sci., 22, 299, 10.1016/S0968-0004(97)01085-2 Nishiyama, 1996, In sity end-labeling detects necrosis of hippocampal pyramidal cells induced by kainic acid, Neurosci. Lett., 212, 139, 10.1016/0304-3940(96)12794-4 Novelli, 1988, Glutamate becomes neurotoxic via theNd, Brain Res., 451, 205, 10.1016/0006-8993(88)90765-2 Olney, 1969, Brain lesion, obesity and other disturbances in mice treated with monosodium glutamate, Science, 164, 719, 10.1126/science.164.3880.719 Paulson, 1997, Intranuclear inclusions of expanded polyglutamine protein in spinocerbellar ataxia type 3, Neuron, 19, 333, 10.1016/S0896-6273(00)80943-5 Portera-Cailliau, 1995, Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models, J. Neurosci., 15, 3775, 10.1523/JNEUROSCI.15-05-03775.1995 Perutz, 1994, Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases, Proc. Natl. Acad. Sci. USA, 91, 5355, 10.1073/pnas.91.12.5355 Quarrell, 1996, The clinical neurology of Huntington's disease, 31 Ranen, 1995, Anticipation and instability of IT-15 (CAG)N, Am. J. Hum. Genet., 57, 593 Reiner, 1988, Differential loss of striatal projection neurons in Huntington's disease, Proc. Natl. Acad. Sci. USA, 85, 5733, 10.1073/pnas.85.15.5733 Ridley, 1996, Rho: Theme and variations, Curr. Biol., 6, 1256, 10.1016/S0960-9822(02)70711-2 Robbins, 1995, A mutation in glyceraldehyde-3-phosphate dehydrogenase alters endocytosis in CHO cells, J. Cell Biol., 130, 1093, 10.1083/jcb.130.5.1093 Roizin, 1979, Neuronal nuclear-cytoplasmic changes in Huntington's chorea: Electron microscope investigations, 95 Ross, 1983, Nuclear membrane indentations in Huntington's chorea, J. Neurol. Sci., 61, 31 Ross, 1995, When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases, Neuron, 15, 493, 10.1016/0896-6273(95)90138-8 Ross, 1997, Intranuclear neuronal inclusions: A common pathogenetic mechanism for glutamine-repeat neurodegenerative diseases, Neuron, 19, 1147, 10.1016/S0896-6273(00)80405-5 Sanberg, 1981, Body weight and dietary factors on Huntington's disease patients compared with matched controls, Med. J. Aust., 1, 407, 10.5694/j.1326-5377.1981.tb135681.x Sapp, 1997, Huntingtin localization in brains of normal and Huntington's disease patients, Ann. Neurol., 42, 604, 10.1002/ana.410420411 Scherzinger, 1997, Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo, Cell, 90, 549, 10.1016/S0092-8674(00)80514-0 Schoepp, 1994, Metabotropic glutamate receptors and neuronal degenerative disorders, Neurobiol. Aging, 15, 261, 10.1016/0197-4580(94)90128-7 Schulz, 1995, Involvement of free radicals in excitotoxicityin vivo, J. Neurochem., 64, 2239, 10.1046/j.1471-4159.1995.64052239.x Seaton, 1997, Free radicals scavengers protect dopaminergic cell lines from apoptosis by complex I inhibitors, Brain Res., 777, 110 Seto-Oshima, 1988, Loss of matrix calcium-binding protein-containing neurons in Huntington's disease, Lancet, 4, 1252, 10.1016/S0140-6736(88)92073-9 Sharp, 1995, Widespread expression of Huntington's disease gene (IT15) protein product, Neuron, 14, 1065, 10.1016/0896-6273(95)90345-3 Sharp, 1996, Neurobiology of Huntington's disease, Neurobiol. Dis., 3, 3, 10.1006/nbdi.1996.0002 Sheline, 1998, Neuronal death in cultured murine cortical cells is induced by inhibition of GAPDH and triosephosphate isomerase, Neurobiol. Dis., 5, 47, 10.1006/nbdi.1998.0177 Skulachev, 1996, Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cell, FEBS Lett., 397, 7, 10.1016/0014-5793(96)00989-1 Snell, 1993, Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease, Nature Genet., 4, 393, 10.1038/ng0893-393 Strong, 1993, Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues, Nature Genet., 5, 259, 10.1038/ng1193-259 Susin, 1996, Bcl-2 inhibits the mitochondrial release of an apoptogenic protease, J. Exp. Med., 184, 1331, 10.1084/jem.184.4.1331 Telenius, 1994, Somatic and gonadal mosaicism of the Huntington's disease gene CAG repeat in brain and sperm, Nature Genet., 6, 409, 10.1038/ng0494-409 Tellez-Nagel, 1974, Studies on brain biopsies of patients with Huntington's chorea, J. Neuropathol. Exp. Neurol., 33, 308, 10.1097/00005072-197404000-00008 Thomas, 1995, DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions, Exp. Neurol., 133, 265, 10.1006/exnr.1995.1029 Thornberry, 1998, Caspases: Enemies within, Science, 281, 1312, 10.1126/science.281.5381.1312 Trottier, 1994, Instability of CAG repeats in Huntington's disease: Relation to parental transmission and age of onset, J. Med. Genet., 31, 377, 10.1136/jmg.31.5.377 Trottier, 1995, Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form, Nature Genet., 10, 104, 10.1038/ng0595-104 Tukamoto, 1997, Huntington's disease gene product, huntingtin, associates with microtubules in vitro, Mol. Brain Res., 51, 8, 10.1016/S0169-328X(97)00205-2 Velier, 1998, Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways, Exp. Neurol., 152, 34, 10.1006/exnr.1998.6832 Vonsattel, 1998, Huntington's disease, J. Neuropathol. Exp. Neurol., 57, 369, 10.1097/00005072-199805000-00001 Vuillaume, 1998, Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease, J. Neurol. Neurosurg. Psychiatry, 64, 758, 10.1136/jnnp.64.6.758 Wagster, 1994, Selective loss of [33, Exp. Neurol., 127, 70, 10.1006/exnr.1994.1081 Wanker, 1997, HIP-1: A huntingtin interacting protein isolated by the yeast two-hybrid system, Hum. Mol. Genet., 6, 487, 10.1093/hmg/6.3.487 Weeks, 1996, Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease, Ann. Neurol., 40, 49, 10.1002/ana.410400110 Wellington, 1997, Toward understanding the molecular pathology of Huntington's disease, Brain Pathol., 7, 979, 10.1111/j.1750-3639.1997.tb00897.x Wexler, 1987, Homozygotes for Huntington's disease, Nature, 326, 194, 10.1038/326194a0 Wyllie, 1981, Cell death: A new classification separating apoptosis from necrosis, 9 Young, 1988, NMDA receptor losses in putamen from patients with Huntington's disease, Science, 241, 981, 10.1126/science.2841762 Yuan, 1993, TheC. elegans, Cell, 75, 641, 10.1016/0092-8674(93)90485-9 Zamzami, 1997, Mitochondrial implication in accidental and programmed cell death: Apoptosis and necrosis, J. Bionerg. Biomembr., 29, 185, 10.1023/A:1022694131572 Zeitlin, 1995, Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue, Nature Genet., 11, 155, 10.1038/ng1095-155